NMRANasdaq United States
Market cap
$302.013 M
$1.63 -0.61%
Close of 7 Aug 2026
Revenue
—
Not reported
Earnings
$236.9M
#935 by earnings
Shares outstanding
182,040,945
Latest filing cover page
P/E ratio
1.3
Cap ÷ net income
Where these numbers come from
Share counts and financials for Neumora Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.